HUTCHMED (China) Limited (HCM)

Sector:

Pharma and Biotech

177.75p
   
  • Change Today:
    -2.75p
  • 52 Week High: 286.00
  • 52 Week Low: 172.00
  • Currency: UK Pounds
  • Shares Issued: 872.34m
  • Volume: 18,719
  • Market Cap: £1,550.58m
  • RiskGrade: 226
  • Beta: 0.01

Dividend Data

  31-Dec-2531-Dec-2431-Dec-2331-Dec-2231-Dec-21
Total Dividendn/an/an/an/an/a
For more dividend details, click here

Fundamentals - based on IFRS

  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Income Statement 31-Dec-25 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21
Continuing Operations          
Revenue 548.51 630.20 838.00 426.41 356.13
Operating Profit/(Loss) 498.69 (1.11) 18.38 (407.69) (328.32)
Net Interest n/a n/a 35.39 8.95 1.48
Profit Before Tax 498.69 (1.11) 58.31 (410.42) (215.74)
Profit After Tax 457.73 38.17 100.78 (360.83) (167.04)
Discontinued Operations          
Profit After Tax n/a n/a n/a n/a n/a
PROFIT FOR THE PERIOD 457.73 38.17 100.78 (360.83) (167.04)
Attributable to:          
Equity Holders of Parent Company 458.55 38.61 101.09 (360.39) (194.65)
Minority Interests (0.82) (0.44) (0.31) (0.45) 27.61
           
Continuing EPS          
Earnings per Share - Basic 53.00¢ 4.00¢ 12.00¢ (43.00¢) (0.25¢)
Earnings per Share - Diluted 52.00¢ 4.00¢ 12.00¢ (43.00¢) (0.25¢)
Earnings per Share - Adjusted 53.00¢ 4.00¢ 12.00¢ (43.00¢) (0.25¢)
Continuing and Discontinued EPS          
Earnings per Share - Basic 53.00¢ 4.00¢ 12.00¢ (43.00¢) (0.25¢)
Earnings per Share - Diluted 52.00¢ 4.00¢ 12.00¢ (43.00¢) (0.25¢)
Earnings per Share - Adjusted 53.00¢ 4.00¢ 12.00¢ (43.00¢) (0.25¢)
           
Dividend per Share n/a n/a n/a n/a n/a
  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Balance Sheet 31-Dec-25 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21
Assets          
Non-Current Assets          
Property, Plant & Equipment 94.62 92.50 104.39 84.67 53.15
Intangible Assets n/a n/a n/a n/a n/a
Investment Properties n/a n/a n/a n/a n/a
Investments 10.86 77.76 48.41 73.78 76.48
Other Financial Assets n/a n/a n/a n/a n/a
Other Non-Current Assets 80.27 37.38 30.13 31.11 30.95
  185.76 207.64 182.93 189.56 160.59
Current Assets          
Inventories n/a n/a 50.26 56.69 35.76
Trade & Other Receivables 126.75 155.54 160.24 152.20 164.62
Cash at Bank & in Hand 1,367.28 836.11 283.59 313.28 377.54
Current Asset Investments n/a n/a n/a 317.72 634.16
Other Current Assets 73.32 74.91 602.75 n/a n/a
  1,567.34 1,066.55 1,096.84 839.89 1,212.08
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 1,753.10 1,274.20 1,279.77 1,029.44 1,372.66
           
Liabilities          
Current Liabilities          
Borrowings n/a n/a 35.08 3.71 26.91
Other Current Liabilities 254.43 298.64 367.95 350.20 284.75
  254.43 298.64 403.03 353.90 311.66
           
Net Current Assets cn/a cn/a cn/a cn/a cn/a
           
Non-Current Liabilities          
Borrowings 93.16 82.81 51.05 23.30 7.16
Provisions 51.55 98.50 1.48 2.71 2.77
Other Non-Current Liabilities 102.70 22.39 80.83 12.66 11.56
  247.41 203.70 133.36 38.67 21.49
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 501.83 502.34 536.39 392.58 333.15
           
Net Assets 1,251.26 771.85 743.39 636.87 1,039.51
           
Capital & Reserves          
Share Capital n/a n/a 87.13 86.48 86.45
Share Premium Account n/a n/a 1,522.45 1,497.27 1,505.20
Other Reserves n/a n/a (8.16) (1.90) (610.33)
Retained Earnings n/a n/a (870.87) (971.48) 5.57
Shareholders Funds 1,237.93 759.93 730.54 610.37 986.89
           
Minority Interests/Other Equity 13.34 11.92 12.85 26.50 52.62
Total Equity 1,251.26 771.85 743.39 636.87 1,039.51
Cash Flow 31-Dec-25 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21
Net Cash Flow From Operating Activities n/a n/a 219.26 (268.60) (204.22)
Returns On Investment & Servicing of Finance fn/a fn/a fn/a fn/a fn/a
Taxation Paid fn/a fn/a fn/a fn/a fn/a
Net Cash Flow from Investing Activities n/a n/a (291.14) 296.59 (306.32)
Acquisitions & Disposals gn/a gn/a gn/a gn/a gn/a
Dividends Paid fn/a fn/a fn/a fn/a fn/a
Management of Liquid Resources cn/a cn/a cn/a cn/a cn/a
Net Cash Flow from Financing Activities n/a n/a 48.66 (82.76) 650.03
Net Increase/Decrease In Cash n/a n/a (23.22) (54.77) 139.49
Ratios - based on IFRS 31-Dec-25 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21
Continuing Operations          
PE Ratio - Adjusted 5.3 78.9 31.7 n/a n/a
PEG - Adjusted 0.0 n/a n/a n/a n/a
Earnings per Share Growth - Adjusted 1,225% -67% n/a n/a n/a
Dividend Cover n/a n/a n/a n/a n/a
Revenue per Share 62.88¢ 72.24¢ 96.06¢ 48.88¢ 40.83¢
Pre-Tax Profit per Share 57.17¢ (0.13¢) 6.68¢ (47.05¢) (24.73¢)
Operating Margin 90.92% (0.18%) 2.19% (95.61%) (92.19%)
Return on Capital Employed 35.72% n/a 2.76% n/a n/a
Continuing & Discontinued Operations          
PE Ratio - Adjusted 5.3 78.9 31.7 n/a n/a
PEG - Adjusted 0.0 n/a n/a n/a n/a
Earnings per Share Growth - Adjusted 1,225% -67% n/a n/a n/a
Dividend Cover n/a n/a n/a n/a n/a
           
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0%
Dividend per Share Growth n/a n/a n/a n/a n/a
Operating Cash Flow per Share n/a n/a 25.14¢ (30.79¢) (0.24¢)
Cash Incr/Decr per Share n/a n/a (2.66¢) (6.28¢) 15.99¢
Net Asset Value per Share (exc. Intangibles) 143.44¢ 88.48¢ 85.22¢ 73.01¢ 119.17¢
Net Gearing n/a -99.13% -27.03% -46.90% -34.80%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page